Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Janus Henderson Group PLC reported a 12.10% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G)

Event Oct 31, 2025 · Filed Nov 7, 2025

Janus Henderson Group PLC reported a 12.10% stake in Enanta Pharmaceuticals, Inc., 3,494,068 shares, as a passive investor on Oct 31, 2025. Filed Nov 7, 2025 (Schedule 13G).

Stake
12.10%
Shares
3,494,068
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
JANUS HENDERSON GROUP PLC12.10%3,494,068
Janus Henderson Biotech Innovation Master Fund Ltd10.60%2,959,525

Source

View original at SEC

Related